RESEARCH NOTE
·
Opthea Ltd (OPT)
Shall we book profit in this biopharmaceutical stock?
Healthcare
Daily
ASX
This report is available to subscribers
The full research note on Opthea Ltd — our view, the levels we are working to and the reasoning behind them — is part of a Kapitales subscription.